SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-034728
Filing Date
2021-09-01
Accepted
2021-09-01 16:07:19
Documents
2
Period of Report
2021-08-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1673
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4488
  Complete submission text file 0000899243-21-034728.txt   7461
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address
Chopas James George (Reporting) CIK: 0001836430 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38276 | Film No.: 211230133